Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.
Įvertink šį straipnį
Norėdami tobulėti, suteikiame jums galimybę įvertinti skaitomą DELFI turinį.
  • 1
  • 2
  • 3
  • 4
  • 5
(0 žmonių įvertino)
0
Leave a comment
or for anonymous commenting click here
By posting, you agree to terms
Read comments Read comments

Lithuania still has room for improvement in terms of recycling

The fast growth of human consumption is the main cause of decreasing land resources and its pollution....

Lithuania celebrates its Independence Day

All Lithuania has celebrated its national day on February 16 . On this occasion we would like to...

Police seize hashish cargo worth 20 mln EUR

The Lithuanian police announced on Wednesday that they have seized 1.5 tons of hashish shipment...

Lithuanian residents are happier (1)

A survey of the emotional climate in Lithuania has shown that residents of the country feel much...

Europe of different medicines: fewer medicines sold in Lithuania and at higher prices than in larger countries (1)

Fewer medicines are sold in Lithuania and their costs are greater than in larger European Union...